🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: rhPSMA-7.3 (18F)

Found 23 matching trials

Imaging Study to Investigate the Safety and Diagnostic Performance of rhPSMA 7.3 (18F) in Newly Diagnosed Prostate Cancer.

PHASE3

A prospective, Phase 3, multi center, single-arm, imaging study investigati...

Status

Completed

Location

University of Alabama at Birmingham

Start Date

2020-03-02

Trial ID

NCT04186819

Treatments Being Tested

rhPSMA-7.3 (18F) Injection Positron Emission Tomography scan

Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection

PHASE1

To determine the dose, safety, radiation dosimetry and efficacy of 177Lu-rh...

Status

Recruiting

Location

Biogenix Molecular LLC

Start Date

2022-07-20

Trial ID

NCT05413850

Treatments Being Tested

Lutetium (177Lu) rhPSMA-10.1 Injection 18F-rhPSMA-7.3 injection (in phase 1 only)

PSMAtrack-tracking Changes in PSMA-PET During Initial Therapy for Metastatic Hormone-sensitive Prostate Cancer

PHASE4

The goal of this clinical trial is to learn if serial PSMA-PET/CT scans can...

Status

Active Not Recruiting

Location

Dana Farber Cancer Institute

Start Date

2024-06-30

Trial ID

NCT06479187

Treatments Being Tested

18F-rhPSMA-7.3 PET/CT

PET Scan Study to Detect Prostate Cancer in Patients with Early PSA Recurrence

PHASE2

Flotufolastat F-18, sold under the brand name Posluma, is a radioactive dia...

Status

Recruiting

Location

AdventHealth

Start Date

2024-09-20

Trial ID

NCT06617481

Treatments Being Tested

18F-rhPSMA-7.3 (Posluma)

Androgen Deprivation Therapy (Relugolix) for the Improvement of Diagnostic Imaging (PSMA PET/CT Scan) in Patients With High Risk or Very High Risk Prostate Cancer, The EnrichPSMA Trial

PHASE2

This phase II trial studies how well a short course of androgen deprivation...

Status

Recruiting

Location

Mayo Clinic in Arizona

Start Date

2025-08-25

Trial ID

NCT07025369

Treatments Being Tested

Biospecimen Collection Computed Tomography Flotufolastat F-18 Gallium Laparoscopic Radical Prostatectomy with Robotics Pelvic Lymphadenectomy Positron Emission Tomography Relugolix

Accuracy of 18F-rhPSMA-7.3 PET/ MRI for Prediction of Lymph Node Metastasis in Localized High-Risk Prostate Cancer

This clinical trial evaluates the use of an imaging scan (18F-rhPSMA-7.3 po...

Status

Recruiting

Location

Mayo Clinic in Florida

Start Date

2024-06-11

Trial ID

NCT06389786

Treatments Being Tested

Bilateral Pelvic Lymph Node Dissection Biospecimen Collection Bone Scan Computed Tomography Electronic Health Record Review Flotufolastat F-18 Gallium Laparoscopic Radical Prostatectomy with Robotics Magnetic Resonance Imaging Positron Emission Tomography

Radioligand Therapy After PSMA PET Guided External Beam Radiotherapy for Treating Post-Prostatectomy Patients With Biochemically Recurrent Prostate Cancer

PHASE1

This phase I trial tests the safety, side effects and best dose of radiolig...

Status

Active Not Recruiting

Location

Emory University Hospital/Winship Cancer Institute

Start Date

2023-11-29

Trial ID

NCT06105918

Treatments Being Tested

Biospecimen Collection Computed Tomography External Beam Radiation Therapy Flotufolastat F-18 Lutetium Lu 177 PSMA-10.1 Positron Emission Tomography Single Photon Emission Computed Tomography

Role of rhPSMA-7.3 PET/CT Imaging in Men With High-Risk Prostate Cancer Following Conventional Imaging and Associated Changes in Medical Management

PHASE3

Study Title: Role of rhPSMA-7.3 PET/CT imaging in men with High-Risk prosta...

Status

Unknown

Location

MidLantic Urology

Start Date

2023-04-27

Trial ID

NCT05799248

Treatments Being Tested

rhPSMA-7.3 (18F)

Optimizing Timing of rhPSMA-7.3 (18F) for Assessing Site(s) of Recurrent Disease Following Radical Prostatectomy

PHASE3

All men following Radical Prostatectomy (RP) at NYU Langone Health undergo ...

Status

Active Not Recruiting

Location

Smilow Comprehensive Prostate Cancer Center

Start Date

2023-01-31

Trial ID

NCT05678322

Treatments Being Tested

18F-Labeled Positron Emission Tomography (PET) Diagnostic Agent PET MRI Imaging

Diagnostic Utility of rhPSMA-7.3 (18F) PET/CT in Men With Prostate Cancer on Active Surveillance

PHASE2

This investigator-initiated, prospective study evaluates the diagnostic uti...

Status

Recruiting

Location

Mount Sinai Hospital / Icahn School of Medicine at Mount Sinai

Start Date

2026-02-10

Trial ID

NCT07285057

Treatments Being Tested

rhPSMA-7.3 (18F) PET/CT Imaging (Flotufolastat F18, POSLUMA®)Flotufolastat F18

Previous Next